Stock price doesn't matter? Company hasn't updated its investor section on website in nearly 3 years. Fins haven't been posted on otc market since June.......... what am I missing here
I find it a little difficult to believe Koosie didnt have a pretty good idea where the $50 million was going to come from when he announced this deal. And since he hasnt asked for an AS increase, he doesnt plan to dilute to pay for it. Maybe a sale of one of the minor patents is in the works. JMO.
Like the way you expressed your view point. Also that it shows that you did some work putting it together. MY take in reading it is RGBY is an all or none possibility, so only put into it what one can afford to loose , hold and wait. GLTA in this one
The LOI is the ROADMAP to the Definitive Agreement. The LOI was probably negotiated over a period of several weeks and was probably in negotiations when RGBP provided a Scope of Work order to Biotech Research Group directing Biotech Research Group to perform an independent assessment of work conducted to date on behalf of the Company by the Company’s Contract Research Organization in order to assist the Company in determining what would be the most efficient actions to undertake in order to commercialize the Company’s NR2F6 intellectual property as well as assist the Company with regulatory strategy with regard to the Company’s NR2F6 intellectual property .
Done some research in regard to the SCOPE OF WORK, this was not a value DETERMINATION report. This was to determine where RGBP WAS IN THE TESTING STAGE OF SCIENTIFIC PROCEDURES. Such evaluation can determine if they missed a procedure step and if any steps need to be repeated.
This is significant that KOOS had decided at this time to have all lab work verified, IMHO from my reading on the SOW (scope of work) ORDER evaluation process.
So to move to this process says Koos and his lab work procedures says they think there close. NOW IS NOT THE TIME TO SELL....HOLD